The use of pulse wave velocity in predicting pre-eclampsia in high-risk women

In this study, we evaluated the diagnostic utility of pulse wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) in high-risk women. Pregnant women at high risk for PE were recruited between 22 and 26 weeks of gestation and were assessed for (a)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension research 2014-08, Vol.37 (8), p.733-740
Hauptverfasser: Katsipi, Irene, Stylianou, Kostas, Petrakis, Ioannis, Passam, Andrew, Vardaki, Eleftheria, Parthenakis, Fragkiskos, Makrygiannakis, Antonios, Daphnis, Eugene, Kyriazis, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 740
container_issue 8
container_start_page 733
container_title Hypertension research
container_volume 37
creator Katsipi, Irene
Stylianou, Kostas
Petrakis, Ioannis
Passam, Andrew
Vardaki, Eleftheria
Parthenakis, Fragkiskos
Makrygiannakis, Antonios
Daphnis, Eugene
Kyriazis, John
description In this study, we evaluated the diagnostic utility of pulse wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) in high-risk women. Pregnant women at high risk for PE were recruited between 22 and 26 weeks of gestation and were assessed for (a) PWV, (b) serum levels of the placental soluble fms-like tyrosine kinase 1 (sFlt-1) protein and uric acid and (c) 24-h urinary protein and calcium excretion. Sensitivities and specificities were derived from receiver operating characteristic curves. Of 118 women recruited, 11 and 10 women developed early-onset PE (
doi_str_mv 10.1038/hr.2014.62
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551611769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551611769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-60c302a88c4917a62ab266b1bc777f999ecdbd36e02e24ce2eb7dab3f23f260b3</originalsourceid><addsrcrecordid>eNo9kEtLw0AUhQdRbK1u_AGSpQip8-oks5RSH1BxU9fDzOSmGc3LmaSl_96EVuHCPXA-zuJD6JbgOcEsfSz8nGLC54KeoSlhPI05JfwcTbEkIpaCiQm6CuELY5ouJLlEE8rFQAg5Re-bAqI-QNTkUduXQ9jrHUQ7KBvrukPk6qj1kDnbuXo7xhhsqas2OD12hdsWsXfhO9o3FdTX6CLXw8jN6c_Q5_Nqs3yN1x8vb8undWwZT7pYYMsw1WlquSSJFlQbKoQhxiZJkkspwWYmYwIwBcotUDBJpg3L6XACGzZD98fd1jc_PYROVS5YKEtdQ9MHRRYLIghJhBzQhyNqfROCh1y13lXaHxTBatSnCq9GfUrQAb477famguwf_fPFfgH6_Wq9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551611769</pqid></control><display><type>article</type><title>The use of pulse wave velocity in predicting pre-eclampsia in high-risk women</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Katsipi, Irene ; Stylianou, Kostas ; Petrakis, Ioannis ; Passam, Andrew ; Vardaki, Eleftheria ; Parthenakis, Fragkiskos ; Makrygiannakis, Antonios ; Daphnis, Eugene ; Kyriazis, John</creator><creatorcontrib>Katsipi, Irene ; Stylianou, Kostas ; Petrakis, Ioannis ; Passam, Andrew ; Vardaki, Eleftheria ; Parthenakis, Fragkiskos ; Makrygiannakis, Antonios ; Daphnis, Eugene ; Kyriazis, John</creatorcontrib><description>In this study, we evaluated the diagnostic utility of pulse wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) in high-risk women. Pregnant women at high risk for PE were recruited between 22 and 26 weeks of gestation and were assessed for (a) PWV, (b) serum levels of the placental soluble fms-like tyrosine kinase 1 (sFlt-1) protein and uric acid and (c) 24-h urinary protein and calcium excretion. Sensitivities and specificities were derived from receiver operating characteristic curves. Of 118 women recruited, 11 and 10 women developed early-onset PE (&lt;34 weeks) and late-onset PE (≥34 weeks), respectively. Of the five diagnostic markers tested, PWV showed the highest detection rate for all cases (21) of PE (81%) and for early-onset PE (82%) at a fixed 10% false-positive rate (FPR), and when combined with sFlt-1, these figures increased to 90% and 92%, respectively. Despite the reduced ability of PWV to predict late-onset PE (detection rate 20%), the combination of PWV with sFlt-1 achieved a detection rate of 50% at a fixed 10% FPR. A suggested cutoff value of 9 m/s for PWV resulted in optimal sensitivity (91%) and specificity (86%) for predicting early-onset PE. This study is the first to show that PWV may be a potentially promising predictor of early-onset PE in women at high risk for PE. The combination of PWV with sFlt-1 may further improve the screening efficacy for predicting PE.</description><identifier>ISSN: 0916-9636</identifier><identifier>EISSN: 1348-4214</identifier><identifier>DOI: 10.1038/hr.2014.62</identifier><identifier>PMID: 24621469</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; Biomarkers ; Calcium - urine ; Female ; Humans ; Pre-Eclampsia - diagnosis ; Predictive Value of Tests ; Pregnancy ; Proteinuria - urine ; Pulse Wave Analysis - methods ; Reference Values ; Risk ; Uric Acid - blood ; Vascular Endothelial Growth Factor Receptor-1 - blood ; Young Adult</subject><ispartof>Hypertension research, 2014-08, Vol.37 (8), p.733-740</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-60c302a88c4917a62ab266b1bc777f999ecdbd36e02e24ce2eb7dab3f23f260b3</citedby><cites>FETCH-LOGICAL-c347t-60c302a88c4917a62ab266b1bc777f999ecdbd36e02e24ce2eb7dab3f23f260b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24621469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katsipi, Irene</creatorcontrib><creatorcontrib>Stylianou, Kostas</creatorcontrib><creatorcontrib>Petrakis, Ioannis</creatorcontrib><creatorcontrib>Passam, Andrew</creatorcontrib><creatorcontrib>Vardaki, Eleftheria</creatorcontrib><creatorcontrib>Parthenakis, Fragkiskos</creatorcontrib><creatorcontrib>Makrygiannakis, Antonios</creatorcontrib><creatorcontrib>Daphnis, Eugene</creatorcontrib><creatorcontrib>Kyriazis, John</creatorcontrib><title>The use of pulse wave velocity in predicting pre-eclampsia in high-risk women</title><title>Hypertension research</title><addtitle>Hypertens Res</addtitle><description>In this study, we evaluated the diagnostic utility of pulse wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) in high-risk women. Pregnant women at high risk for PE were recruited between 22 and 26 weeks of gestation and were assessed for (a) PWV, (b) serum levels of the placental soluble fms-like tyrosine kinase 1 (sFlt-1) protein and uric acid and (c) 24-h urinary protein and calcium excretion. Sensitivities and specificities were derived from receiver operating characteristic curves. Of 118 women recruited, 11 and 10 women developed early-onset PE (&lt;34 weeks) and late-onset PE (≥34 weeks), respectively. Of the five diagnostic markers tested, PWV showed the highest detection rate for all cases (21) of PE (81%) and for early-onset PE (82%) at a fixed 10% false-positive rate (FPR), and when combined with sFlt-1, these figures increased to 90% and 92%, respectively. Despite the reduced ability of PWV to predict late-onset PE (detection rate 20%), the combination of PWV with sFlt-1 achieved a detection rate of 50% at a fixed 10% FPR. A suggested cutoff value of 9 m/s for PWV resulted in optimal sensitivity (91%) and specificity (86%) for predicting early-onset PE. This study is the first to show that PWV may be a potentially promising predictor of early-onset PE in women at high risk for PE. The combination of PWV with sFlt-1 may further improve the screening efficacy for predicting PE.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biomarkers</subject><subject>Calcium - urine</subject><subject>Female</subject><subject>Humans</subject><subject>Pre-Eclampsia - diagnosis</subject><subject>Predictive Value of Tests</subject><subject>Pregnancy</subject><subject>Proteinuria - urine</subject><subject>Pulse Wave Analysis - methods</subject><subject>Reference Values</subject><subject>Risk</subject><subject>Uric Acid - blood</subject><subject>Vascular Endothelial Growth Factor Receptor-1 - blood</subject><subject>Young Adult</subject><issn>0916-9636</issn><issn>1348-4214</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLw0AUhQdRbK1u_AGSpQip8-oks5RSH1BxU9fDzOSmGc3LmaSl_96EVuHCPXA-zuJD6JbgOcEsfSz8nGLC54KeoSlhPI05JfwcTbEkIpaCiQm6CuELY5ouJLlEE8rFQAg5Re-bAqI-QNTkUduXQ9jrHUQ7KBvrukPk6qj1kDnbuXo7xhhsqas2OD12hdsWsXfhO9o3FdTX6CLXw8jN6c_Q5_Nqs3yN1x8vb8undWwZT7pYYMsw1WlquSSJFlQbKoQhxiZJkkspwWYmYwIwBcotUDBJpg3L6XACGzZD98fd1jc_PYROVS5YKEtdQ9MHRRYLIghJhBzQhyNqfROCh1y13lXaHxTBatSnCq9GfUrQAb477famguwf_fPFfgH6_Wq9</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Katsipi, Irene</creator><creator>Stylianou, Kostas</creator><creator>Petrakis, Ioannis</creator><creator>Passam, Andrew</creator><creator>Vardaki, Eleftheria</creator><creator>Parthenakis, Fragkiskos</creator><creator>Makrygiannakis, Antonios</creator><creator>Daphnis, Eugene</creator><creator>Kyriazis, John</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>The use of pulse wave velocity in predicting pre-eclampsia in high-risk women</title><author>Katsipi, Irene ; Stylianou, Kostas ; Petrakis, Ioannis ; Passam, Andrew ; Vardaki, Eleftheria ; Parthenakis, Fragkiskos ; Makrygiannakis, Antonios ; Daphnis, Eugene ; Kyriazis, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-60c302a88c4917a62ab266b1bc777f999ecdbd36e02e24ce2eb7dab3f23f260b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biomarkers</topic><topic>Calcium - urine</topic><topic>Female</topic><topic>Humans</topic><topic>Pre-Eclampsia - diagnosis</topic><topic>Predictive Value of Tests</topic><topic>Pregnancy</topic><topic>Proteinuria - urine</topic><topic>Pulse Wave Analysis - methods</topic><topic>Reference Values</topic><topic>Risk</topic><topic>Uric Acid - blood</topic><topic>Vascular Endothelial Growth Factor Receptor-1 - blood</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katsipi, Irene</creatorcontrib><creatorcontrib>Stylianou, Kostas</creatorcontrib><creatorcontrib>Petrakis, Ioannis</creatorcontrib><creatorcontrib>Passam, Andrew</creatorcontrib><creatorcontrib>Vardaki, Eleftheria</creatorcontrib><creatorcontrib>Parthenakis, Fragkiskos</creatorcontrib><creatorcontrib>Makrygiannakis, Antonios</creatorcontrib><creatorcontrib>Daphnis, Eugene</creatorcontrib><creatorcontrib>Kyriazis, John</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katsipi, Irene</au><au>Stylianou, Kostas</au><au>Petrakis, Ioannis</au><au>Passam, Andrew</au><au>Vardaki, Eleftheria</au><au>Parthenakis, Fragkiskos</au><au>Makrygiannakis, Antonios</au><au>Daphnis, Eugene</au><au>Kyriazis, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of pulse wave velocity in predicting pre-eclampsia in high-risk women</atitle><jtitle>Hypertension research</jtitle><addtitle>Hypertens Res</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>37</volume><issue>8</issue><spage>733</spage><epage>740</epage><pages>733-740</pages><issn>0916-9636</issn><eissn>1348-4214</eissn><abstract>In this study, we evaluated the diagnostic utility of pulse wave velocity (PWV) alone or in combination with other diagnostic markers in predicting pre-eclampsia (PE) in high-risk women. Pregnant women at high risk for PE were recruited between 22 and 26 weeks of gestation and were assessed for (a) PWV, (b) serum levels of the placental soluble fms-like tyrosine kinase 1 (sFlt-1) protein and uric acid and (c) 24-h urinary protein and calcium excretion. Sensitivities and specificities were derived from receiver operating characteristic curves. Of 118 women recruited, 11 and 10 women developed early-onset PE (&lt;34 weeks) and late-onset PE (≥34 weeks), respectively. Of the five diagnostic markers tested, PWV showed the highest detection rate for all cases (21) of PE (81%) and for early-onset PE (82%) at a fixed 10% false-positive rate (FPR), and when combined with sFlt-1, these figures increased to 90% and 92%, respectively. Despite the reduced ability of PWV to predict late-onset PE (detection rate 20%), the combination of PWV with sFlt-1 achieved a detection rate of 50% at a fixed 10% FPR. A suggested cutoff value of 9 m/s for PWV resulted in optimal sensitivity (91%) and specificity (86%) for predicting early-onset PE. This study is the first to show that PWV may be a potentially promising predictor of early-onset PE in women at high risk for PE. The combination of PWV with sFlt-1 may further improve the screening efficacy for predicting PE.</abstract><cop>England</cop><pmid>24621469</pmid><doi>10.1038/hr.2014.62</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0916-9636
ispartof Hypertension research, 2014-08, Vol.37 (8), p.733-740
issn 0916-9636
1348-4214
language eng
recordid cdi_proquest_miscellaneous_1551611769
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Biomarkers
Calcium - urine
Female
Humans
Pre-Eclampsia - diagnosis
Predictive Value of Tests
Pregnancy
Proteinuria - urine
Pulse Wave Analysis - methods
Reference Values
Risk
Uric Acid - blood
Vascular Endothelial Growth Factor Receptor-1 - blood
Young Adult
title The use of pulse wave velocity in predicting pre-eclampsia in high-risk women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A40%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20pulse%20wave%20velocity%20in%20predicting%20pre-eclampsia%20in%20high-risk%20women&rft.jtitle=Hypertension%20research&rft.au=Katsipi,%20Irene&rft.date=2014-08-01&rft.volume=37&rft.issue=8&rft.spage=733&rft.epage=740&rft.pages=733-740&rft.issn=0916-9636&rft.eissn=1348-4214&rft_id=info:doi/10.1038/hr.2014.62&rft_dat=%3Cproquest_cross%3E1551611769%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551611769&rft_id=info:pmid/24621469&rfr_iscdi=true